Substituted pyridines, pyridazines, pyrimidines, and 1,2,3-triazines as bruton's tyrosine kinase inhibitors
US12070457B2 · kind B2 · utility
0Cited by
0References
38Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 31, 2022 |
| Grant date | Aug 27, 2024 |
| Priority date | — |
| Expiry date | Aug 31, 2042 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07B2200/05
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to heteroaryl heterocyclic compounds, e.g., the compound of the formula shown below, pharmaceutical compositions comprising same, methods for preparing same, and uses thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.